Shire/Noven Daytrana Second-Line? Physicians Should Consider Oral Agents First, Cmte. Says

FDA's Psychopharmacologic Drugs Advisory Committee suggests that broad initial use of the methylphenidate patch should be discouraged because of skin sensitization issues.